Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262
Income Statement
Earnings Waterfall
Jiangsu Nhwa Pharmaceutical Co Ltd
Revenue
|
5B
CNY
|
Cost of Revenue
|
-1.4B
CNY
|
Gross Profit
|
3.6B
CNY
|
Operating Expenses
|
-2.5B
CNY
|
Operating Income
|
1.1B
CNY
|
Other Expenses
|
-74.2m
CNY
|
Net Income
|
1B
CNY
|
Income Statement
Jiangsu Nhwa Pharmaceutical Co Ltd
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
2 236
N/A
|
2 310
+3%
|
2 375
+3%
|
2 418
+2%
|
2 501
+3%
|
2 566
+3%
|
2 627
+2%
|
2 694
+3%
|
2 767
+3%
|
2 851
+3%
|
2 937
+3%
|
3 004
+2%
|
3 018
+0%
|
3 097
+3%
|
3 181
+3%
|
3 274
+3%
|
3 394
+4%
|
3 482
+3%
|
3 581
+3%
|
3 764
+5%
|
3 858
+2%
|
3 982
+3%
|
4 090
+3%
|
4 167
+2%
|
4 149
0%
|
3 837
-8%
|
3 535
-8%
|
3 326
-6%
|
3 361
+1%
|
3 528
+5%
|
4 648
+32%
|
4 783
+3%
|
3 936
-18%
|
4 928
+25%
|
4 072
-17%
|
4 164
+2%
|
4 299
+3%
|
4 485
+4%
|
4 698
+5%
|
4 834
+3%
|
5 042
+4%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(1 359)
|
(1 405)
|
(1 450)
|
(1 479)
|
(1 510)
|
(1 548)
|
(1 577)
|
(1 634)
|
(1 615)
|
(1 679)
|
(1 731)
|
(1 685)
|
(1 638)
|
(1 648)
|
(1 638)
|
(1 680)
|
(1 783)
|
(1 826)
|
(1 847)
|
(1 876)
|
(1 721)
|
(1 763)
|
(1 721)
|
(1 682)
|
(1 561)
|
(1 325)
|
(1 100)
|
(901)
|
(843)
|
(893)
|
(1 175)
|
(1 225)
|
(933)
|
(1 210)
|
(985)
|
(984)
|
(1 037)
|
(1 150)
|
(1 231)
|
(1 333)
|
(1 403)
|
|
Gross Profit |
877
N/A
|
905
+3%
|
926
+2%
|
940
+2%
|
992
+6%
|
1 018
+3%
|
1 051
+3%
|
1 060
+1%
|
1 151
+9%
|
1 172
+2%
|
1 206
+3%
|
1 319
+9%
|
1 380
+5%
|
1 449
+5%
|
1 543
+6%
|
1 594
+3%
|
1 611
+1%
|
1 655
+3%
|
1 734
+5%
|
1 889
+9%
|
2 137
+13%
|
2 219
+4%
|
2 368
+7%
|
2 485
+5%
|
2 588
+4%
|
2 513
-3%
|
2 435
-3%
|
2 426
0%
|
2 518
+4%
|
2 635
+5%
|
3 473
+32%
|
3 558
+2%
|
3 003
-16%
|
3 718
+24%
|
3 087
-17%
|
3 179
+3%
|
3 262
+3%
|
3 335
+2%
|
3 467
+4%
|
3 501
+1%
|
3 638
+4%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(661)
|
(679)
|
(679)
|
(679)
|
(719)
|
(729)
|
(750)
|
(748)
|
(846)
|
(860)
|
(880)
|
(983)
|
(1 039)
|
(1 084)
|
(1 160)
|
(1 150)
|
(1 171)
|
(1 194)
|
(1 228)
|
(1 363)
|
(1 545)
|
(1 597)
|
(1 701)
|
(1 766)
|
(1 876)
|
(1 792)
|
(1 698)
|
(1 660)
|
(1 707)
|
(1 785)
|
(2 407)
|
(2 461)
|
(2 125)
|
(2 633)
|
(2 173)
|
(2 233)
|
(2 317)
|
(2 351)
|
(2 419)
|
(2 410)
|
(2 527)
|
|
Selling, General & Administrative |
(649)
|
(667)
|
(666)
|
(666)
|
(665)
|
(710)
|
(736)
|
(736)
|
(780)
|
(835)
|
(856)
|
(958)
|
(954)
|
(1 071)
|
(1 152)
|
(1 186)
|
(1 094)
|
(1 224)
|
(1 252)
|
(1 267)
|
(1 387)
|
(1 439)
|
(1 503)
|
(1 593)
|
(1 708)
|
(1 628)
|
(1 506)
|
(1 443)
|
(1 480)
|
(1 514)
|
(2 020)
|
(2 070)
|
(1 788)
|
(2 177)
|
(1 812)
|
(1 848)
|
(1 862)
|
(1 912)
|
(1 945)
|
(1 888)
|
(1 971)
|
|
Research & Development |
0
|
0
|
0
|
0
|
(48)
|
0
|
0
|
0
|
(55)
|
0
|
0
|
0
|
(73)
|
0
|
0
|
0
|
(111)
|
0
|
0
|
(52)
|
(160)
|
(147)
|
(184)
|
(182)
|
(175)
|
(185)
|
(214)
|
(236)
|
(230)
|
(277)
|
(368)
|
(375)
|
(327)
|
(453)
|
(387)
|
(408)
|
(427)
|
(463)
|
(501)
|
(548)
|
(515)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
(6)
|
0
|
0
|
0
|
(10)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(24)
|
0
|
0
|
0
|
(25)
|
0
|
0
|
0
|
(24)
|
0
|
0
|
0
|
(41)
|
0
|
0
|
0
|
(74)
|
0
|
0
|
0
|
(91)
|
|
Other Operating Expenses |
(12)
|
(12)
|
(12)
|
(13)
|
(1)
|
(20)
|
(14)
|
(12)
|
(1)
|
(24)
|
(25)
|
(26)
|
(1)
|
(13)
|
(9)
|
36
|
45
|
30
|
23
|
(45)
|
26
|
(11)
|
(14)
|
9
|
32
|
20
|
22
|
19
|
27
|
6
|
(19)
|
(16)
|
32
|
(4)
|
25
|
23
|
46
|
25
|
26
|
25
|
49
|
|
Operating Income |
216
N/A
|
226
+5%
|
247
+9%
|
260
+5%
|
273
+5%
|
288
+6%
|
302
+5%
|
312
+3%
|
305
-2%
|
312
+2%
|
325
+4%
|
335
+3%
|
341
+2%
|
365
+7%
|
383
+5%
|
445
+16%
|
440
-1%
|
462
+5%
|
506
+10%
|
526
+4%
|
592
+13%
|
622
+5%
|
668
+7%
|
719
+8%
|
713
-1%
|
721
+1%
|
737
+2%
|
766
+4%
|
811
+6%
|
850
+5%
|
1 066
+25%
|
1 097
+3%
|
878
-20%
|
1 084
+23%
|
914
-16%
|
946
+4%
|
945
0%
|
984
+4%
|
1 047
+6%
|
1 091
+4%
|
1 111
+2%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(13)
|
(11)
|
(12)
|
(12)
|
(13)
|
(15)
|
(17)
|
(15)
|
(11)
|
(6)
|
(3)
|
0
|
2
|
1
|
4
|
5
|
6
|
8
|
6
|
9
|
11
|
9
|
11
|
8
|
14
|
65
|
68
|
71
|
46
|
40
|
58
|
65
|
47
|
51
|
42
|
48
|
58
|
71
|
67
|
69
|
71
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
0
|
0
|
0
|
(1)
|
0
|
0
|
6
|
6
|
6
|
6
|
1
|
44
|
0
|
0
|
(0)
|
(1)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
2
|
2
|
1
|
1
|
2
|
2
|
3
|
3
|
7
|
7
|
7
|
7
|
5
|
5
|
4
|
5
|
(0)
|
(1)
|
(0)
|
(2)
|
(1)
|
(2)
|
(3)
|
(1)
|
(4)
|
(5)
|
(5)
|
(7)
|
(6)
|
(5)
|
(12)
|
(10)
|
(9)
|
(12)
|
(7)
|
(7)
|
(13)
|
(15)
|
(14)
|
(14)
|
(14)
|
|
Pre-Tax Income |
205
N/A
|
217
+6%
|
236
+9%
|
250
+6%
|
261
+4%
|
275
+5%
|
287
+4%
|
300
+4%
|
301
+0%
|
313
+4%
|
330
+6%
|
343
+4%
|
359
+5%
|
371
+3%
|
392
+6%
|
455
+16%
|
445
-2%
|
469
+5%
|
512
+9%
|
538
+5%
|
608
+13%
|
635
+4%
|
682
+8%
|
726
+6%
|
767
+6%
|
781
+2%
|
800
+2%
|
829
+4%
|
851
+3%
|
884
+4%
|
1 113
+26%
|
1 152
+3%
|
916
-20%
|
1 124
+23%
|
949
-16%
|
987
+4%
|
990
+0%
|
1 040
+5%
|
1 101
+6%
|
1 147
+4%
|
1 169
+2%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(33)
|
(35)
|
(38)
|
(40)
|
(40)
|
(42)
|
(44)
|
(46)
|
(46)
|
(48)
|
(50)
|
(53)
|
(57)
|
(59)
|
(60)
|
(70)
|
(70)
|
(73)
|
(77)
|
(77)
|
(89)
|
(93)
|
(104)
|
(110)
|
(110)
|
(111)
|
(107)
|
(114)
|
(123)
|
(127)
|
(161)
|
(159)
|
(118)
|
(139)
|
(118)
|
(124)
|
(110)
|
(121)
|
(119)
|
(119)
|
(134)
|
|
Income from Continuing Operations |
173
|
183
|
198
|
210
|
221
|
233
|
243
|
254
|
255
|
265
|
280
|
290
|
302
|
312
|
332
|
385
|
375
|
396
|
434
|
460
|
519
|
542
|
578
|
617
|
657
|
670
|
693
|
715
|
727
|
758
|
952
|
992
|
798
|
985
|
831
|
863
|
880
|
919
|
981
|
1 028
|
1 034
|
|
Income to Minority Interest |
4
|
4
|
3
|
3
|
2
|
2
|
3
|
3
|
3
|
4
|
5
|
7
|
8
|
13
|
16
|
16
|
19
|
16
|
13
|
12
|
6
|
7
|
7
|
7
|
6
|
5
|
1
|
(1)
|
2
|
1
|
3
|
6
|
(0)
|
2
|
4
|
4
|
21
|
21
|
17
|
17
|
3
|
|
Net Income (Common) |
176
N/A
|
186
+6%
|
201
+8%
|
213
+6%
|
223
+5%
|
235
+5%
|
246
+4%
|
257
+4%
|
258
+1%
|
269
+4%
|
284
+6%
|
297
+4%
|
310
+4%
|
325
+5%
|
347
+7%
|
400
+15%
|
395
-1%
|
411
+4%
|
447
+9%
|
472
+6%
|
525
+11%
|
549
+5%
|
585
+7%
|
623
+7%
|
663
+6%
|
676
+2%
|
694
+3%
|
714
+3%
|
729
+2%
|
759
+4%
|
955
+26%
|
998
+5%
|
798
-20%
|
986
+24%
|
834
-15%
|
867
+4%
|
901
+4%
|
940
+4%
|
998
+6%
|
1 045
+5%
|
1 037
-1%
|
|
EPS (Diluted) |
0.18
N/A
|
0.19
+6%
|
0.21
+11%
|
0.22
+5%
|
0.23
+5%
|
0.24
+4%
|
0.25
+4%
|
0.26
+4%
|
0.26
N/A
|
0.27
+4%
|
0.28
+4%
|
0.29
+4%
|
0.31
+7%
|
0.32
+3%
|
0.34
+6%
|
0.39
+15%
|
0.39
N/A
|
0.4
+3%
|
0.44
+10%
|
0.47
+7%
|
0.52
+11%
|
0.54
+4%
|
0.57
+6%
|
0.61
+7%
|
0.66
+8%
|
0.67
+2%
|
0.69
+3%
|
0.7
+1%
|
0.72
+3%
|
0.75
+4%
|
0.95
+27%
|
1
+5%
|
0.79
-21%
|
0.98
+24%
|
0.83
-15%
|
0.86
+4%
|
0.89
+3%
|
0.93
+4%
|
0.99
+6%
|
1.04
+5%
|
1.03
-1%
|